| 1. | encompassed 5 RCTs including the Study to Prevent Non-Insulin-Dependent Diabetes (STOP-NIDDM) which showed a relative risk ... |
| 2. | Most cases of type 1 diabetes are diagnosed in patients younger than 18 years. But type 1 diabetes is increasingly recognized as a disorder ... diabetes. Using age BMI C-peptide concentration and OGTT results the algorithm was highly predictive of type 1 diabetes ... |
| 3. | was a landmark study in which patients with type 1 diabetes mellitus who received targeted intensive insulin therapy experienced delayed onset ... compared with regular human insulin in patients with type 1 diabetes mellitus (T1DM).52 In clinical trials insulin ... |
| 4. | GLP glucagon-like peptide; OD once daily; T1DM type 1 diabetes mellitus; T2DM type 2 diabetes mellitus. ... |
| 5. | consistent disease-oriented findings). Patients with type 1 diabetes who have case management and “intense control” experience ... The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. ... |
| 6. | High and low hemoglobin glycation phenotypes in type I diabetes: a challenge for interpretation of glycemic control. ... Levine BS Bernstein R O’Shea M. Feasibility of improved blood glucose control in patients with insulin-dependent diabetes mellitus. ... |
| 7. | ketoacidosis and insulin dependency has traditionally been sufficient to diagnose type 1 diabetes while onset in older obese patients with primary insulin ... insulin deficiency due to premature beta-cell failure in type 1 diabetes as well as a relative insulin deficiency due ... |
| 8. | complications to progress to symptomatic disease. Patients with type 1 diabetes who are generally younger are more likely to live ... Type 1 Diabetes. There are few data on all-cause mortality in patients with type 1 diabetes because of the low event rate. ... |
| 9. | Patients with type 1 diabetes will require an injectable basal insulin (intermediate or long acting) in conjunction with the inhaled insulin. ... Amylin is cosecreted with insulin so patients with type 1 diabetes have an absolute deficiency of amylin while those with type ... |
| 10. | 6 TABLE 1 provides criteria for screening for type 2 diabetes in children. The adolescent in the case presented has several risk factors ... 34 The pediatric experience with insulin is extensive but mostly in type 1 diabetes. The potential need for and benefits of insulin ... |